Antiviral and Antimicrobial Peptides: Comparison
View Latest Version
Please note this is a comparison between Version 2 by Nora Tang and Version 1 by Angus Watson.

Antimicrobial peptides (AMPs) are a ubiquitous class of secretable molecules involved in innate immunity via direct interaction with pathogens. AMP research has sought to describe the highly conserved cysteine rich C-domains of peptides, which determine molecular function; however, investigations into such molecular functions have generally been limited to antibacterial and antifungal defence in both vertebrates and invertebrates, with little research focusing on mollusc antiviral AMPs. Mollusc AMPs can be broadly divided into the following five groups: defensins, big defensins, mytilins, myticins, mytimacins, and mytimycins. All groups possess antibacterial activity, though few have been tested for antiviral activity, and thus the mollusc antiviral AMP mode of action is poorly understood. However, proposed modes of action of antiviral AMPs include targeting viral entry, viral uncoating, and inhibition of viral replication and endosomal escape.

  • mollusc
  • abalone
  • hemolymph
  • galectin
  • lectin
  • antimicrobial peptide

1. Defensins and Big Defensins

Defensins are the most characterised group of AMPs in both vertebrates and invertebrates, though no pure fractions of mollusc defensins have successfully been tested for antiviral activity. MGD-1, first isolated in M. galloprovincialis, is approximately 39 aa long and exhibits a common motif in defensins, termed an alpha-beta loop, consisting of an α-helix and two β-sheets [50,51][1][2]. Additionally, MGD-1 inhibits the growth of many Gram-positive bacteria by binding to lipid II, a precursor to peptidoglycan [50,52][1][3]. Though not tested for antiviral defence in molluscs, a 10 amino acid long fragment of MGD-1 has been demonstrated to inhibit mortality in the Chelicerate Palaemon serratus against White Spot Syndrome Virus by directly binding to and disrupting viral envelopes [44,53][4][5]. In these studies, a 10 amino acid long fragment of MGD-1 constrained by two disulphide bonds in a stable beta hairpin structure was shown to be the critical domain required for viral inhibition [44][4]. Moreover, MGD-1 breaks the conformity of other defensins such as the antibacterial MGD-2, possessing two additional C-domains, which is suggestive of a greater spectrum of molecular functions and renders the structure similar to Mytilus genus AMPs [44,51][4][2].
Big defensins are, as the word suggests, structurally larger (70–180 aa) than defensins, and possess both C-domains and an N-terminal [6,54][6][7]. Big defensins are believed to have given rise to vertebrate β-defensins, which lost the N-terminal during evolution from basal chordates to vertebrates [54][7]. The additional N-terminal of big defensins often provides additional protein functions, including antimicrobial activity [54][7]. To date, the mollusc big defensins have all only been tested for antibacterial and antifungal activity, including the three described in C. gigas; Cg-BigDef1, Cg-BigDef2, and Cg-BigDef3 [52,55][3][8]. Specifically, these three big defensins are active against both Gram-negative and Gram-positive species, and also exhibit bactericidal activity against Staphylococcous aureus multiresistant to antibiotics and Vibrio spp., by disrupting bacterial membranes through hydrophobic interactions [41,54][9][7].
Very few investigations have described big defensin diversity or gene organization, thus it is possible that there are yet undiscovered mollusc defensins that contain antimicrobial roles, including antiviral activity, which may be harnessed to manufacture both invertebrate and human infection treatments.

2. Mytilus AMPs

Mytilus AMPs are those peptides isolated solely in members of the mollusc genus Mytilus [56][10]. These AMPs include the classes myticins, mytilins, mytimycins, and mytimacins [56][10]. All three identified myticins have expressed antibacterial and antifungal activity, but only myticin-C possesses antiviral activity [56][10]. Myticin-C has gained the most attention for a single AMP, for its various roles in innate immunity. First isolated in the Blue Mussel (M. galloprovincialis), cysteine-rich AMP prevents the viral replication of OsHV-1 in molluscs and, interestingly, HSV-2 in humans [56][10]. Myticin-C was also shown to play a role in danger signaling, and is upregulated in response to tissue damage in M. galloprovinicalis [57][11]. Interestingly, myticin-C expresses a high nucleotide sequence variability across more than 100 mussels, perhaps suggesting that it is derived from a more ancient and common nucleotide sequence, and due to its highly conserved and ubiquitous nature, may play additional roles in innate immunity [58][12].
The five mytilin AMPs protect against bacterial and fungal infections, however, their antiviral roles are currently unknown [59][13]. Of the AMP class, mytilin-B is the most researched, due to its potent defensive roles against Gram-positive bacteria in Mytilus edulis [60][14]. It has been determined that mytilin-B contains an α-helix linked by four disulfide bridges to two β-sheets [61][15]. Though mytilin-B has not been tested for antiviral activity in molluscs, a 13 amino-acid-long fragment of one disulfide bridge and an acid loop structure has been tested against White Spot Syndrome Virus in the prawn, P. serratus [53][5]. The study found that the fragment, designed to mimic a common sequence found in defensins, offered minimal protection and animals died four days post challenge [53][5]. In comparison, whole mytilin-B provided an approximate 70% survival rate for 13 days post challenge, suggesting the mytilin-B possesses a separate structural attribute to other defensins that provides antimicrobial defence [53][5]. The structurally similar mytilin-A is also shown to inhibit herpes simplex virus-1 (HSV-1) replication during in vitro experiments, due to a dense cysteine-rich structure that competes for binding sites, and thus prevents viral attachment [60][14]. Therefore, it is possible mytilin-B and mytilin-A possess unknown antiviral roles in the Mytilus genus, the description of which may yield a broad spectrum of antimicrobial defence for all molluscs.
Mytimycins and mytimacins are the least studied Mytilus genus AMPs and display antibacterial and antifungal activity, though they have not been tested for antiviral activity [6,62][6][16]. Mytimycins and mytimacins are generally larger than other Mytilus genus AMPs and defensins, at approximately 80–100 aa [6,61][6][15]. They have been shown to possess ten C-domains, which is more than any other Mytilus AMP [63][17], and as C-domains are related to peptide function, it is likely that the structurally similar mytimycins and mytimacins possess currently undescribed antiviral activity, which should be the focus of future studies [6].

3. Hemocyanins

Hemocyanins (Hcs) constitute 50–90% of hemolymph and are copper-containing glycoproteins that transport oxygen, possess antimicrobial activity, and have C-domains that encode for peptides with AMP-like activity [64,65][18][19]. The antimicrobial activity of Hcs and equivalent glycoproteins, such as cavortin in C. gigas, include antiviral defence, as demonstrated by in vitro assays involving HSV-1 [66,67][20][21]. Purified abalone Hc (from Haliotis rubra), has been shown to bind to specific viral surface glycoproteins of HSV-1, inhibiting viral attachment and entry into Vero cells in vitro, however, it displayed no antiviral activity when added to the culture post HSV-1 infection [66][20].
The C-domain of Hcs encode for many Hc derived peptides (Hcdps), such as the highly conserved haliotisin, which is present in many of molluscs [68][22]. The C-domain of other proteins have been shown to encode for peptides with AMP-like activity, such as histone H2A in the abalone Haliotis discus discus, which encodes for the peptide abhisin [69][23]. Such domain-encoded peptides with AMP-like activity have only been tested for antibacterial and antifungal activity, with no investigations into antiviral properties. As these domain-encoded peptides are still relatively novel, investigations into their function remain very limited, and future research will hopefully include antiviral activity screens.
AMPs represent hopeful prospects for future mollusc innate-immunity studies, due to their highly conserved regions that aid in describing previously undiscovered peptides, as well as their role in antimicrobial defence. Moreover, AMP applications reach beyond mollusc innate immunity, and include the possibility of being repurposed to produce higher order species of antimicrobial compounds. Thus, investigations into mollusc AMPs are vital and should include a broader description of the functions and structures of currently undescribed peptides, and should also incorporate structural knowledge of AMPs to discover novel molecules. 

References

  1. De Zoysa, M.; Whang, I.; Lee, Y.; Lee, S.; Lee, J.-S.; Lee, J. Defensin from Disk Abalone Haliotis Discus Discus: Molecular Cloning, Sequence Characterization and Immune Response against Bacterial Infection. Fish Shellfish Immunol. 2010, 28, 261–266.
  2. Mitta, G.; Vandenbulcke, F.; Hubert, F.; Roch, P. Mussel defensins are synthesised and processed in granulocytes then released into the plasma after bacterial challenge. J. Cell Sci. 1999, 112 Pt 23, 4233–4242.
  3. Destoumieux-Garzón, D.; Rosa, R.D.; Schmitt, P.; Barreto, C.; Vidal-Dupiol, J.; Mitta, G.; Gueguen, Y.; Bachère, E. Antimicrobial Peptides in Marine Invertebrate Health and Disease. Philos. Trans. R. Soc. B Biol. Sci. 2016, 371, 20150300.
  4. Roch, P.; Yang, Y.; Toubiana, M.; Aumelas, A. NMR Structure of Mussel Mytilin, and Antiviral–Antibacterial Activities of Derived Synthetic Peptides. Dev. Comp. Immunol. 2008, 32, 227–238.
  5. Dupuy, J.W.; Bonami, J.R.; Roch, P. A Synthetic Antibacterial Peptide from Mytilus galloprovincialis Reduces Mortality Due to White Spot Syndrome Virus in Palaemonid Shrimp. J. Fish Dis. 2004, 27, 57–64.
  6. Gerdol, M.; De Moro, G.; Manfrin, C.; Venier, P.; Pallavicini, A. Big Defensins and Mytimacins, New AMP Families of the Mediterranean Mussel Mytilus Galloprovincialis. Dev. Comp. Immunol. 2012, 36, 390–399.
  7. Loth, K.; Vergnes, A.; Barreto, C.; Voisin, S.N.; Meudal, H.; Da Silva, J.; Bressan, A.; Belmadi, N.; Bachère, E.; Aucagne, V.; et al. The Ancestral N-Terminal Domain of Big Defensins Drives Bacterially Triggered Assembly into Antimicrobial Nanonets. mBio 2019, 10, e01821-19.
  8. Buda De Cesare, G.; Cristy, S.A.; Garsin, D.A.; Lorenz, M.C. Antimicrobial Peptides: A New Frontier in Antifungal Therapy. mBio 2020, 11, e02123-20.
  9. Rosa, R.D.; Santini, A.; Fievet, J.; Bulet, P.; Destoumieux-Garzón, D.; Bachère, E. Big Defensins, a Diverse Family of Antimicrobial Peptides That Follows Different Patterns of Expression in Hemocytes of the Oyster Crassostrea gigas. PLoS ONE 2011, 6, e25594.
  10. Zannella, C.; Mosca, F.; Mariani, F.; Franci, G.; Folliero, V.; Galdiero, M.; Tiscar, P.G.; Galdiero, M. Microbial Diseases of Bivalve Mollusks: Infections, Immunology and Antimicrobial Defense. Mar. Drugs 2017, 15, 182.
  11. Rey-Campos, M.; Moreira, R.; Valenzuela-Muñoz, V.; Gallardo-Escárate, C.; Novoa, B.; Figueras, A. High Individual Variability in the Transcriptomic Response of Mediterranean Mussels to Vibrio Reveals the Involvement of Myticins in Tissue Injury. Sci. Rep. 2019, 9, 3569.
  12. Costa, M.M.; Dios, S.; Alonso-Gutierrez, J.; Romero, A.; Novoa, B.; Figueras, A. Evidence of High Individual Diversity on Myticin C in Mussel (Mytilus Galloprovincialis). Dev. Comp. Immunol. 2009, 33, 162–170.
  13. Mitta, G.; Hubert, F.; Dyrynda, E.A.; Boudry, P.; Roch, P. Mytilin B and MGD2, Two Antimicrobial Peptides of Marine Mussels: Gene Structure and Expression Analysis. Dev. Comp. Immunol. 2000, 24, 381–393.
  14. Carriel-Gomes, M.C.; Kratz, J.M.; Barracco, M.A.; Bachére, E.; Barardi, C.R.M.; Simões, C.M.O. In Vitro Antiviral Activity of Antimicrobial Peptides against Herpes Simplex Virus 1, Adenovirus, and Rotavirus. Mem. Inst. Oswaldo Cruz 2007, 102, 469–472.
  15. Tincu, J.A.; Taylor, S.W. Antimicrobial Peptides from Marine Invertebrates. Antimicrob. Agents Chemother. 2004, 48, 3645–3654.
  16. Sperstad, S.V.; Haug, T.; Blencke, H.-M.; Styrvold, O.B.; Li, C.; Stensvåg, K. Antimicrobial Peptides from Marine Invertebrates: Challenges and Perspectives in Marine Antimicrobial Peptide Discovery. Biotechnol. Adv. 2011, 29, 519–530.
  17. Zhong, J.; Wang, W.; Yang, X.; Yan, X.; Liu, R. A Novel Cysteine-Rich Antimicrobial Peptide from the Mucus of the Snail of Achatina Fulica. Peptides 2013, 39, 1–5.
  18. Coates, C.J.; Nairn, J. Diverse Immune Functions of Hemocyanins. Dev. Comp. Immunol. 2014, 45, 43–55.
  19. Dang, V.T.; Benkendorff, K.; Speck, P. In Vitro Antiviral Activity against Herpes Simplex Virus in the Abalone Haliotis Laevigata. J. Gen. Virol. 2011, 92, 627–637.
  20. Talaei Zanjani, N.; Miranda-Saksena, M.; Valtchev, P.; Diefenbach, R.J.; Hueston, L.; Diefenbach, E.; Sairi, F.; Gomes, V.G.; Cunningham, A.L.; Dehghani, F. Abalone Hemocyanin Blocks the Entry of Herpes Simplex Virus 1 into Cells: A Potential New Antiviral Strategy. Antimicrob. Agents Chemother. 2016, 60, 1003–1012.
  21. Green, T.J.; Robinson, N.; Chataway, T.; Benkendorff, K.; O’Connor, W.; Speck, P. Evidence That the Major Hemolymph Protein of the Pacific Oyster, Crassostrea Gigas, Has Antiviral Activity against Herpesviruses. Antivir. Res. 2014, 110, 168–174.
  22. Zhuang, J.; Coates, C.J.; Zhu, H.; Zhu, P.; Wu, Z.; Xie, L. Identification of Candidate Antimicrobial Peptides Derived from Abalone Hemocyanin. Dev. Comp. Immunol. 2015, 49, 96–102.
  23. De Zoysa, M.; Nikapitiya, C.; Whang, I.; Lee, J.-S.; Lee, J. Abhisin: A Potential Antimicrobial Peptide Derived from Histone H2A of Disk Abalone (Haliotis Discus Discus). Fish Shellfish Immunol. 2009, 27, 639–646.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)
ScholarVision Creations
Feedback